BÜHLMANN Laboratories AG Announces Worldwide Collaboration with Beckman Coulter for BUHLMANN fCAL® turbo and fPELA® turbo Assays

BÜHLMANN Laboratories AG Announces Worldwide Collaboration with Beckman Coulter for BUHLMANN fCAL® turbo and fPELA® turbo Assays

BÜHLMANN Laboratories AG, a leading manufacturer of specialty, high-quality in-vitro diagnostic and research assays, is pleased to announce the collaboration with Beckman Coulter for a worldwide distribution of the BÜHLMANN fCAL® turbo assay & BÜHLMANN fPELA® turbo assay... - September 26, 2024

BÜHLMANN Laboratories AG Launches New fPELA® turbo Automated, Random Access Pancreatic Elastase Test

BÜHLMANN Laboratories AG Launches New fPELA® turbo Automated, Random Access Pancreatic Elastase Test

BÜHLMANN fPELA® turbo (FDA Exempt. For in vitro Diagnostic Use) is an in vitro diagnostic assay intended for the quantitation of pancreatic elastase in human stool, is now commercially available in the US. - June 24, 2020

BÜHLMANN Laboratories AG Receives FDA Clearance for CALEX® Cap Fecal Calprotectin Extraction Device

BÜHLMANN Laboratories AG Receives FDA Clearance for CALEX® Cap Fecal Calprotectin Extraction Device

BÜHLMANN CALEX® Cap, a single use tube intended for the preparation of human stool samples to be used with the BÜHLMANN fCAL® turbo, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US. - September 25, 2019

BÜHLMANN Laboratories AG Receives FDA Clearance for Its fCAL® turbo Automated, Random Access Calprotectin Test

BÜHLMANN Laboratories AG Receives FDA Clearance for Its fCAL® turbo Automated, Random Access Calprotectin Test

BÜHLMANN fCAL® turbo, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US. - June 27, 2019

BUHLMANN Diagnostics Corp. Announces New Distribution Agreement with Meridian Biosciences, Inc.

BUHLMANN Diagnostics Corp. Announces New Distribution Agreement with Meridian Biosciences, Inc.

BUHLMANN Diagnostics Corp. has embarked on a new partnership with Meridian Bioscience, Inc. for the distribution of the 510(k) cleared, BÜHLMANN fCAL® ELISA, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool. - January 31, 2019

BÜHLMANN Laboratories AG Receives FDA Clearance for Its fCAL® ELISA Calprotectin Test

BÜHLMANN fCAL® ELISA, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US. - June 14, 2018

BÜHLMANN Laboratories AG Announces New Health Canada Licences for Quantum Blue® Infliximab Assay, IBDoc®, and CALEX® Cap Device

BÜHLMANN Laboratories AG Announces New Health Canada Licences for Quantum Blue® Infliximab Assay, IBDoc®, and CALEX® Cap Device

BÜHLMANN Laboratories AG’s Quantum Blue® Infliximab, lateral flow assay for rapid quantification of Infliximab in Serum; IBDoc®, the first in-vitro diagnostic home testing device measuring the inflammatory marker fecal calprotectin at home; as well as CALEX® Cap Device for rapid stool extraction are now commercially available in Canada and are Health Canada licenced. - May 02, 2017

BÜHLMANN Laboratories AG Announces New Health Canada License for the BÜHLMANN fCAL® turbo Assay

BÜHLMANN Laboratories AG Announces New Health Canada License for the BÜHLMANN fCAL® turbo Assay

BÜHLMANN Laboratories AG's immunoturbidimetric assay for fecal calprotectin quantification, BÜHLMANN fCAL® turbo is now commercially available in Canada and is Health Canada licensed. - May 24, 2016

BÜHLMANN Laboratories Opens North American Affiliate

BÜHLMANN Laboratories Opens North American Affiliate

BÜHLMANN Laboratories is proud to announce the availability of its products directly from its new North American affiliate, BUHLMANN Diagnostics Corp (BDC) in Southern New Hampshire. - January 11, 2016

BUHLMANN Laboratories Announces New, Direct US Affiliate

BUHLMANN Laboratories Announces New, Direct US Affiliate

BÜHLMANN Laboratories is proud to announce the establishment of its North American affiliate, BUHLMANN Diagnostics Corp (BDC) in Southern New Hampshire. - November 16, 2015

Press Releases 1 - 10 of 10